Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2

Siyu Chen1,2,3, Tamar Basiashvili1,2, Joshua Hutchings1

  • 1Department of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA.

Insights

Leucine-rich repeat kinase 2 (LRRK2) forms filaments on microtubules even in its inactive state. This finding is crucial for understanding Parkinson's Disease (PD) pathogenesis and LRRK2's complex behavior.

Area of Science:

  • Neuroscience
  • Structural Biology
  • Molecular Biology

Background:

  • Parkinson's Disease (PD) is a common neurodegenerative disorder.
  • Mutations in leucine-rich repeat kinase 2 (LRRK2) are a primary cause of familial PD.
  • LRRK2's kinase activity is elevated in pathogenic mutations and it associates with cellular structures like microtubules.

Purpose of the Study:

  • To investigate if leucine-rich repeat kinase 2 (LRRK2) can form filaments on microtubules in its autoinhibited (inactive) state.
  • To characterize the structural features and stability of autoinhibited LRRK2 filaments on microtubules.

Main Methods:

  • Utilized *in situ* cryo-electron tomography (cryo-ET) to visualize LRRK2 structures.
  • Examined full-length wild-type (WT) and Parkinson's Disease-linked mutant LRRK2.
  • Analyzed LRRK2 oligomerization and filament formation on microtubules.

Main Results:

  • Full-length LRRK2, including PD-linked mutants, forms filaments on microtubules in its autoinhibited state.
  • These filaments exhibit distinct structural interfaces, including a novel interaction involving N-terminal repeats.
  • Autoinhibited LRRK2 filaments display different helical parameters and are less stable than active LRRK2 filaments.

Conclusions:

  • LRRK2 can oligomerize and form filaments on microtubules irrespective of its kinase activity state.
  • The autoinhibited state of LRRK2 reveals new structural insights, particularly involving its N-terminal domains.
  • Understanding LRRK2 filament formation in different conformational states is vital for Parkinson's Disease research.